Hanson & Doremus Investment Management Novo Nordisk A S Transaction History
Hanson & Doremus Investment Management
- $748 Million
- Q2 2025
A detailed history of Hanson & Doremus Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 5,076 shares of NVO stock, worth $253,140. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,076
Previous 5,076
-0.0%
Holding current value
$253,140
Previous $352,000
0.57%
% of portfolio
0.05%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,746Shares Held
338MCall Options Held
10.8MPut Options Held
15.9M-
Jennison Associates LLC18.9MShares$942 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$738 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$618 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$614 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$592 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $113B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...